About this Journal Submit a Manuscript Table of Contents
Clinical and Developmental Immunology
Volume 2012 (2012), Article ID 369546, 9 pages
http://dx.doi.org/10.1155/2012/369546
Review Article

Clinical Relevance of Autoantibodies in Patients with Autoimmune Bullous Dermatosis

Department of Dermatology and Allergology, Albert Szent-Györgyi Medical Center, University of Szeged, Korányi Fasor 6, 6720 Szeged, Hungary

Received 4 November 2012; Accepted 10 December 2012

Academic Editor: Dimitrios P. Bogdanos

Copyright © 2012 Lilla Mihályi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Husz, E. Heszler, and L. Török, “Paraneoplasmic bullosis,” Dermatologica, vol. 141, no. 6, pp. 421–427, 1970. View at Scopus
  2. I. L. Jukić and B. Marinović, “Significance of immunofluorescence in the diagnosis of autoimmune bullous dermatoses,” Clinics in Dermatology, vol. 29, no. 4, pp. 389–397, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. W. R. Gammon, R. A. Briggaman, and A. O. Inman III, “Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin,” Journal of Investigative Dermatology, vol. 82, no. 2, pp. 139–144, 1984. View at Scopus
  4. T. Hashimoto, M. M. Ogawa, A. Konohana, and T. Nishikawa, “Detection of pemphigus vulgaris and pemphigus foliaceus antigens by immunoblot analysis using different antigen sources,” Journal of Investigative Dermatology, vol. 94, no. 3, pp. 327–331, 1990. View at Scopus
  5. M. Kiss, S. Husz, K. Molnár, and A. Dobozy, “Identification of different circulating autoantibodies in patients with bullous pemphigoid and pemphigus vulgaris by means of immunoblotting,” Acta Microbiologica et Immunologica Hungarica, vol. 43, no. 2-3, pp. 115–123, 1996. View at Scopus
  6. S. Husz, M. Kiss, K. Molnár et al., “Development of a system for detection of circulating antibodies against hemidesmosomal proteins in patients with bullous pemphigoid,” Archives of Dermatological Research, vol. 292, no. 5, pp. 217–224, 2000. View at Scopus
  7. I. Laczkó, E. Vass, G. K. Tóth, I. Marczinovits, M. Kiss, and S. Husz, “Conformational consequences of coupling bullous pemphigoid antigenic peptides to glutathione-S-Transferase and their diagnostic significance,” Journal of Peptide Science, vol. 6, no. 8, pp. 378–386, 2000. View at Publisher · View at Google Scholar
  8. L. Borradori and A. Sonnenberg, “Structure and function of hemidesmosomes: more than simple adhesion complexes,” Journal of Investigative Dermatology, vol. 112, no. 4, pp. 411–418, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Guo, L. Degenstein, J. Bowling et al., “Gene targeting of BPAG1: abnormalities in mechanical strength and cell migration in stratified epithelia and neurologic degeneration,” Cell, vol. 81, no. 2, pp. 233–243, 1995. View at Scopus
  10. C. Ruhrberg and F. M. Watt, “The plakin family: versatile organizers of cytoskeletal architecture,” Current Opinion in Genetics and Development, vol. 7, no. 3, pp. 392–397, 1997. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Molnar, G. Van Der Steege, M. F. Jonkman et al., “Two type XVII collagen (BP180) mRNA transcripts in human keratinocytes: a long and a short form,” Clinical and Experimental Dermatology, vol. 25, no. 1, pp. 71–76, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Nishiyama, S. Amano, M. Tsunenaga et al., “The importance of laminin 5 in the dermal-epidermal basement membrane,” Journal of Dermatological Science, vol. 24, supplement 1, pp. S51–S59, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. C. A. Egan and J. J. Zone, “Linear IgA bullous dermatosis,” International Journal of Dermatology, vol. 38, no. 11, pp. 818–827, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. L. S. Chan, “Ocular and oral mucous membrane pemphigoid (cicatricial pemphigoid),” Clinics in Dermatology, vol. 30, no. 1, pp. 34–37, 2012. View at Publisher · View at Google Scholar
  15. N. Domloge-Hultsch, G. J. Anhalt, W. R. Gammon et al., “Antiepiligrin cicatricial pemphigoid: a subepithelial bullous disorders,” Archives of Dermatology, vol. 130, no. 12, pp. 1521–1529, 1994. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Kiss, A. Perenyi, I. Marczinovits et al., “Autoantibodies to human α6 integrin in patients with bullous pemphigoid,” Annals of the New York Academy of Sciences, vol. 1051, pp. 104–110, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Schmidt and D. Zillikens, “Modern diagnosis of autoimmune blistering skin diseases,” Autoimmunity Reviews, vol. 10, no. 2, pp. 84–89, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Radoš, “Autoimmune blistering diseases: histologic meaning,” Clinics in Dermatology, vol. 29, no. 4, pp. 377–388, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. N. J. Korman, “Bullous pemphigoid,” Dermatologic Clinics, vol. 11, no. 3, pp. 483–498, 1993. View at Scopus
  20. K. Csorba, S. Schmidt, F. Florea et al., “Development of an ELISA for sensitive and specific detection of IgA autoantibodies against BP180 in pemphigoid diseases,” Orphanet Journal of Rare Diseases, vol. 6, no. 1, article 31, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Di Zenzo, R. della Torre, G. Zambruno, and L. Borradori, “Bullous pemphigoid: from the clinic to the bench,” Clinics in Dermatology, vol. 30, no. 1, pp. 3–16, 2012. View at Publisher · View at Google Scholar
  22. I. Schneider and S. Husz, “Seborrhoic pemphigoid,” Hautarzt, vol. 37, no. 3, pp. 149–151, 1986. View at Scopus
  23. T. P. Chorzelski, S. Jablonska, and E. Maciejowska, “Coexistence of malignancies with bullous pemphigoid,” Archives of Dermatology, vol. 114, no. 6, p. 964, 1978. View at Publisher · View at Google Scholar · View at Scopus
  24. R. A. C. Graham-Brown, “Bullous pemphigoid with figurate erythema associated with carcinoma of the bronchus,” British Journal of Dermatology, vol. 117, no. 3, pp. 385–388, 1987. View at Scopus
  25. L. Misery, F. Cambazard, R. Rimokh et al., “Bullous pemphigoid associated with chronic B-cell lymphatic ieukaemia: the anti-230-kDa autoantibody is not synthesized by leukaemic cells,” British Journal of Dermatology, vol. 141, no. 1, pp. 155–157, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Muramatsu, T. Iida, H. Tada et al., “Bullous pemphigoid associated with internal malignancies: identification of 180-kDa antigen by Western immunoblotting,” British Journal of Dermatology, vol. 135, no. 5, pp. 782–784, 1996. View at Scopus
  27. B. Lindelof, N. Islam, G. Eklund, and L. Arfors, “Pemphigoid and cancer,” Archives of Dermatology, vol. 126, no. 1, pp. 66–68, 1990. View at Publisher · View at Google Scholar · View at Scopus
  28. V. A. Venning and F. Wojnarowska, “The association of bullous pemphigoid and malignant disease: a case control study,” British Journal of Dermatology, vol. 123, no. 4, pp. 439–445, 1990. View at Scopus
  29. M. Mehravaran, R. Gyulai, S. Husz, and A. Dobozy, “Drug-induced erythema multiforme-like bullous pemphigoid,” Acta Dermato-Venereologica, vol. 79, no. 3, p. 233, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. E. Licarete, S. Ganz, M. J. Recknagel et al., “Prevalence of collagen VII-specific autoantibodies in patients with autoimmune and inflammatory diseases,” BMC Immunology, vol. 13, article 16, 2012. View at Publisher · View at Google Scholar
  31. R. M. Vodegel, M. Kiss, M. C. J. M. De Jong et al., “The use of skin substrates deficient in basement membrane molecules for the diagnosis of subepidermal autoimmune bullous disease,” European Journal of Dermatology, vol. 8, no. 2, pp. 83–85, 1998. View at Scopus
  32. C. Baykal, G. Okan, and R. Sarica, “Childhood bullous pemphigoid developed after the first vaccination,” Journal of the American Academy of Dermatology, vol. 44, no. 2, supplement, pp. 348–350, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. Z. Erbagci, “Childhood bullous pemphigoid following hepatitis B immunization,” Journal of Dermatology, vol. 29, no. 12, pp. 781–785, 2002. View at Scopus
  34. E. Szabo, S. Husz, and L. Kovacs, “Coexistent atypical bullous pemphigoid and systemic lupus erythematosus,” British Journal of Dermatology, vol. 104, no. 1, pp. 71–75, 1981. View at Scopus
  35. L. Torok, S. Husz, I. Korom, et al., “Bullous systemic lupus erythematosus with malignant papulosis atrophicans and Schönlein-Henoch vasculitis symptoms,” Acta Dermatovenerologica Alpina, Pannonica et Adriatica, vol. 2, no. 2, pp. 60–64, 1992.
  36. R. Gyulai, M. Kiss, M. Mehravaran et al., “Atypical autoimmune blistering dermatosis associated with Sjögren's syndrome,” Acta Dermato-Venereologica, vol. 82, no. 6, pp. 462–464, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. L. Török, S. Husz, H. Ócsai, et al., “Pemphigus vegetans presenting as acrodermatitis continua suppurativa,” European Journal of Dermatology, vol. 13, no. 6, pp. 579–581, 2003. View at Scopus
  38. M. Mehravaran, M. Morvay, K. Molnár et al., “Juvenile pemphigus foliaceus,” British Journal of Dermatology, vol. 139, no. 3, pp. 496–499, 1998. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Meurer, “Immunosuppressive therapy for autoimmune bullous diseases,” Clinics in Dermatology, vol. 30, no. 1, pp. 78–83, 2012. View at Publisher · View at Google Scholar
  40. G. Zambruno and L. Borradori, “Rituximab immunotherapy in pemphigus: therapeutic effects beyond B-cell depletion,” Journal of Investigative Dermatology, vol. 128, no. 12, pp. 2745–2747, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Kiss, S. Husz, T. Jánossy et al., “Experimental bullous pemphigoid generated in mice with an antigenic epitope of the human hemidesmosomal protein BP230,” Journal of Autoimmunity, vol. 24, no. 1, pp. 1–10, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. W. F. Lever, “Pemphigus,” Medicine, vol. 32, no. 1, pp. 1–123, 1953. View at Scopus
  43. E. H. Beutner and R. E. Jordon, “Demonstration of skin antibodies in sera of pemphigus vulgaris patients by indirect immunofluorescent staining,” Proceedings of the Society for Experimental Biology and Medicine, vol. 117, pp. 505–510, 1964. View at Scopus
  44. R. E. Jordon, E. H. Beutner, E. Witebsky, G. Blumental, W. L. Hale, and W. F. Lever, “Basement zone antibodies in bullous pemphigoid.,” Journal of the American Medical Association, vol. 200, no. 9, pp. 751–756, 1967. View at Publisher · View at Google Scholar · View at Scopus